WO2002026996A3 - Regulation d'enzyme humaine de type phospholipase c specifique du phosphatidylinositol - Google Patents
Regulation d'enzyme humaine de type phospholipase c specifique du phosphatidylinositol Download PDFInfo
- Publication number
- WO2002026996A3 WO2002026996A3 PCT/EP2001/011012 EP0111012W WO0226996A3 WO 2002026996 A3 WO2002026996 A3 WO 2002026996A3 EP 0111012 W EP0111012 W EP 0111012W WO 0226996 A3 WO0226996 A3 WO 0226996A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- enzyme
- specific phospholipase
- human phosphatidylinositol
- regulation
- reagents
- Prior art date
Links
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 title abstract 3
- 108090000790 Enzymes Proteins 0.000 title abstract 3
- 102000015439 Phospholipases Human genes 0.000 title abstract 3
- 108010064785 Phospholipases Proteins 0.000 title abstract 3
- 150000003905 phosphatidylinositols Chemical class 0.000 title abstract 3
- 102000004190 Enzymes Human genes 0.000 title abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002210514A AU2002210514A1 (en) | 2000-09-27 | 2001-09-24 | Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23555200P | 2000-09-27 | 2000-09-27 | |
US60/235,552 | 2000-09-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002026996A2 WO2002026996A2 (fr) | 2002-04-04 |
WO2002026996A3 true WO2002026996A3 (fr) | 2002-09-26 |
Family
ID=22885960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/011012 WO2002026996A2 (fr) | 2000-09-27 | 2001-09-24 | Regulation d'enzyme humaine de type phospholipase c specifique du phosphatidylinositol |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002210514A1 (fr) |
WO (1) | WO2002026996A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0127206D0 (en) * | 2001-11-13 | 2002-01-02 | Univ Liverpool | Treatment of inflammatory conditions |
AU2003242759A1 (en) * | 2002-06-26 | 2004-01-19 | Bayer Healthcare Ag | Regulation of human phospholipase c-like protein |
US20100284992A1 (en) * | 2006-10-02 | 2010-11-11 | The Regents Of The University Of Colorado, A Body Corporate | Phospholipase C and Method of Use |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001075067A2 (fr) * | 2000-03-31 | 2001-10-11 | Hyseq, Inc. | Nouveaux acides nucleiques et polypeptides |
-
2001
- 2001-09-24 WO PCT/EP2001/011012 patent/WO2002026996A2/fr active Application Filing
- 2001-09-24 AU AU2002210514A patent/AU2002210514A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001075067A2 (fr) * | 2000-03-31 | 2001-10-11 | Hyseq, Inc. | Nouveaux acides nucleiques et polypeptides |
Non-Patent Citations (3)
Title |
---|
DATABASE SWISSPROT [online] 1 July 1989 (1989-07-01), SUH ET AL.: "1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE PHOSPHODIESTERASE DELTA 1 (EC 3.1.4.11) (PLC-DELTA-1) (PHOSPHOLIPASE C-DELTA-1) (PLC-III).", XP002199648, Database accession no. P10688 * |
DATABASE SWISSPROT [online] 1 May 2000 (2000-05-01), KIKUNO ET AL.: "KIAA1069 Protein (Fragment)", XP002199647, Database accession no. Q9UPT3 * |
KIKUNO ET AL.: "Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.", DNA RESEARCH, vol. 6, 1999, pages 197 - 205, XP000852618 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002210514A1 (en) | 2002-04-08 |
WO2002026996A2 (fr) | 2002-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002010403A3 (fr) | Regulation d'une enzyme humaine de type phospholipase c a phosphatidylinositol specifique | |
WO2002026996A3 (fr) | Regulation d'enzyme humaine de type phospholipase c specifique du phosphatidylinositol | |
WO2002006453A3 (fr) | Regulation de protease a serine humaine de type desc1 | |
WO2002031160A3 (fr) | Regulation de l'enzyme de type a2 phospholipase humaine | |
WO2002000704A3 (fr) | Regulation d'une enzyme du type phospholipase c humaine | |
WO2002031162A3 (fr) | Regulation de l'enzyme du type phospholipase a2 humaine | |
WO2002031125A3 (fr) | Regulation de l'enzyme semblable a phospholipase a2 humaine | |
WO2002042435A3 (fr) | Regulation de la tyrosine phosphatase humaine | |
WO2002020732A3 (fr) | Régulation d'enzyme humaine de type map kinase phosphatase | |
WO2001077149A3 (fr) | Regulation d'une proteine gpcr type cyslt2 humaine | |
WO2002031161A3 (fr) | Regulation de l'enzyme humaine de type phospholipase | |
WO2002092798A3 (fr) | Regulation d'une proteine humaine de type 2c de phosphatase acide phosphatidique | |
WO2002020747A3 (fr) | Regulation de l'enzyme humaine du type tyrosine phosphatase | |
WO2002090543A3 (fr) | Régulation de la protéine semblable à celle de type 2c de la phosphatase de l'acide phosphatidique humain | |
WO2003052088A3 (fr) | Regulation de la sialyltransferase humaine | |
WO2002062974A3 (fr) | Regulation de la proteine humaine elongase hselo1 | |
WO2002088362A3 (fr) | Regulation d'une proteine semblable a la prostaglandine-f synthase 1 humaine | |
WO2002033056A3 (fr) | Regulation de serine-threonine kinase humaine | |
WO2002061058A3 (fr) | Regulation de la phospholipase humaine | |
WO2002062975A3 (fr) | Regulation de la proteine humaine du type elongase hselo1 | |
WO2002033095A3 (fr) | Regulation de serine-threonine proteine kinase humaine | |
WO2002055710A3 (fr) | Regulation de l'acide phosphatase pourpre humain | |
WO2002057461A3 (fr) | Regulation de la metalloprotease a zinc de type adam-ts humaine | |
WO2003018815A3 (fr) | Regulation de la grk humaine | |
WO2002006455A3 (fr) | Regulation de l'enzyme de type trypsine protease humaine des voies respiratoires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |